An expert discusses the evolution of ROS1 testing in non-small cell lung cancer, highlighting the shift from FISH-based methods to comprehensive next-generation sequencing of both tissue and plasma, ...

Next-generation sequencing enhances a biologics manufacturer's ability to detect and identify unknown or unexpected contaminants.

LONDON, GREATER LONDON, UNITED KINGDOM, September 12, 2025 /EINPresswire.com/ -- What Is The Projected Market Size & Growth Rate Of The Next Generation Tissue Biomarkers Market? The market size for ...

CURE spoke with Dr. Xiuning Le during the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer.

LONDON, GREATER LONDON, UNITED KINGDOM, September 12, 2025 /EINPresswire.com/ -- Genetic Analysis Market Growth Forecast: What To Expect By 2025? The market size for genetic analysis has seen a swift ...

Qiagen N.V. (NYSE:QGEN), a global leader in molecular diagnostics and sample preparation technologies, continues to advance ...

PredicineCARE, a urine-based test, is under FDA review as a companion diagnostic for bladder cancer, building on previous ...

Every three seconds, one life is lost to sepsis, according to the Global Sepsis Alliance. It is a life-threatening, dysregulated immune response to infection and remains a leading cause of death ...

Researchers from the Belgian Federal Institute Sciensano, as part of the DARWIN project, have developed a proof-of-concept ...

The non-coding genome, once dismissed as "junk DNA", is now recognized as a fundamental regulator of gene expression and a key player in understanding complex diseases. Following the landmark ...